ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease

Wang, Hongyan; Zhang, Yuxue; Liu, Yupeng; Li, Hui; Xu, Ruiling; Fu, Hongmei; Yan, Chaoqi*; Qu, Bo*哈尔滨医科大学
Frontiers in Endocrinology2023-4-21DOI: 10.3389/fendo.2023.1163682
2被引10阅读
引用收藏
分享

摘要

ObjectivesObesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and assess their screening ability. Methods12,658 subjects aged 18-75 at the Health Center of a Class III Grade A Hospital were included, who were divided into MAFLD and non-MAFLD groups. Spearman's rank correlation was used to study the correlation between MAFLD and obesity measurement indexes. Receiver operating characteristic (ROC) curves were used to calculate the area under the curve (AUC) to evaluate their screening accuracy. ResultsMAFLD had strong correlation with traditional BMI and new index LAP. ROC analysis showed that BMI had the highest AUC (0.89), followed by LAP (0.87). Stratification by BMI, LAP had the highest AUC (0.90) for MAFLD in population without obesity (BMI< 23kg/m(2)), and its optimal cutoff value was 20.75, with a sensitivity and specificity of 85.9% and 79.0%, respectively. ConclusionsWe proposed a two-step screening strategy for MAFLD, combining BMI and LAP, and defined a high-risk population for MAFLD as follows: 1) BMI >= 23 kg/m(2); and 2) BMI< 23 kg/m(2) and LAP >= 20.75.

学科与关键词

关键词
MAFLDobesity measurement indexbody mass indexlipid accumulation productscreening abilityscreening strategy
相关
加载中…
  • Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population
    Cai, Jinwei; Lin, Cuiting; Lai, Shuiqing; Liu, Yingshan; Liang, Min; Qin, Yingfen; Liang, Xinghuan; Tan, Aihua; Gao, Yong; Lu, Zheng; Wu, Chunlei; Huang, Shengzhu; Yang, Xiaobo; Zhang, Haiying; Kuang, Jian*; Mo, ZengnanLipids in Health and Disease, 2021, 20(1): 145.被引 10
  • Evaluation of Different Anthropometric Indicators for Screening for Nonalcoholic Fatty Liver Disease in Elderly Individuals
    Zhang, Yan; Li, Bo; Liu, Nan; Wang, Peixi*; He, JinghuaInternational Journal of Endocrinology, 2021, 2021: 6678755.被引 8
  • Discrepancies between Nonalcoholic and Metabolic- associated Fatty Liver Disease by Multiple Steatosis Assessment
    Shao, Congxiang; Ye, Junzhao; Li, Xin; Lin, Yansong; Feng, Shiting; Liao, Bing; Wang, Wei; Gong, Xiaorong*; Zhong, Bihui*Journal of Clinical and Translational Hepatology, 2022.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2023-04-21
卷期
第 14 卷
页码
1163682
DOI
10.3389/fendo.2023.1163682
成果收录
SCIE

作者

  • W

    Wang, Hongyan (第一作者)

    2 · harbin med univ

  • Z

    Zhang, Yuxue

    harbin med univ

查看全部 8 位作者收起作者
  • L

    Liu, Yupeng

    wenzhou med univ

  • L

    Li, Hui

    2 · harbin med univ

  • X

    Xu, Ruiling

    2 · harbin med univ

  • F

    Fu, Hongmei

    2 · harbin med univ

  • Y

    Yan, Chaoqi (通讯)

    2 · harbin med univ

  • Q

    Qu, Bo (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417